110143-66-3Relevant articles and documents
Preparation method of (R)-2-hydroxyl-4-phenyl butyric acid
-
Paragraph 0015-0023, (2017/07/21)
The invention discloses a preparation method of (R)-2-hydroxyl-4-phenyl butyric acid. The method comprises the following steps: carrying out catalytic reduction on 2-oxo-4-phenyl butyric acid-L-menthyl ester in an alcohol system to obtain (R)-2-hydroxyl-4
Angiotensin-Converting Enzyme Inhibitors: Perhydro-1,4-thiazepin-5-one Derivatives
Yanagisawa, Hiroaki,Ishihara, Sadao,Ando, Akiko,Kanazaki, Takuro,Miyamoto, Shuichi,et al.
, p. 1984 - 1991 (2007/10/02)
α-amino>-5-oxoperhydro-1,4-thiazepin-4-yl>acetic acids (monoester monoacids) and their dicarboxylic acids having the hydrophobic substituents at the 2- or 3-position of the thiazepinone ring were prepared and assayed for angiotensin-converting enzyme (ACE) inhibitory activity.The dicarboxylic acids having the pseudoequatorial amino groups at the 6-position and the pseudoequatorial hydrophobic substituents at the 2- or 3-position of the chair conformation of the thiazepinone ring had potent in vitro inhibitory activity.The monoester monoacids having the hydrophobic substituents at the 2-position suppressed pressor response to angiotensin I for a longer duration than those having the substituents at the 3-position when administered orally.The structure-activity relationship was studied by conformational energy calculations of the thiazepinone ring.